Korean Manufacturer Warned for Quality Control, Drug Storage

Drug Industry Daily
A A
The FDA hit Korean drug supplier Barox with a warning letter for quality control, drug labeling and product storage issues at its Seongnam, Gyeonggi facility.

To View This Article:

Login

Subscribe To Drug Industry Daily